Chapter 6: Chromosome Mutations: Number and Arrangement

Loading audio…

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

If there is an issue with this chapter, please let us know → Contact Us

Nondisjunction during meiosis is presented as the primary mechanism generating aneuploid gametes, with monosomy and trisomy conditions exemplified through human syndromes including Down syndrome, Edwards syndrome, and Patau syndrome, where correlations between maternal age and chromosomal abnormality incidence are established. Polyploidy, particularly prevalent in plant species, is examined through autopolyploidy and allopolyploidy, demonstrating how chromosome set multiplication generates reproductive isolation and new species. The chapter then transitions to structural rearrangements beginning with deletions, illustrated through cri du chat syndrome resulting from loss of genetic material on the short arm of chromosome 5, and duplications, which contribute to genetic redundancy and evolutionary novelty according to Ohno's theoretical framework regarding gene evolution. Inversions are classified as paracentric or pericentric based on centromere involvement, with detailed analysis of how inversion loops during meiosis suppress viable crossover products. Translocations, especially Robertsonian translocations, are contextualized through familial Down syndrome, where balanced chromosome carriers can produce imbalanced offspring through segregation errors during meiosis. The chapter addresses fragile sites as chromosomal regions exhibiting heightened breakage susceptibility, with fragile-X syndrome detailed as resulting from expansion of trinucleotide repeats in the FMR1 gene followed by epigenetic silencing through DNA methylation. Connections between chromosomal instability and malignant transformation are explored through fragile site-associated tumor suppressors. The chapter concludes by situating chromosomal mutations within broader contexts of evolutionary change, clinical genetics, and ethical considerations surrounding prenatal testing and genetic counseling.